Overview

Evaluation of Physiologic and Standard Sex Steroid Replacement Regimens in Women With Premature Ovarian Failure

Status:
Completed
Trial end date:
2006-11-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to determine whether physiological sex steroid replacement improves parameters of skeletal, cardiovascular and reproductive health of women treated with current sex steroid replacement regimens.
Phase:
Phase 4
Details
Lead Sponsor:
University of Edinburgh
Treatments:
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Ethinyl Estradiol
Norethindrone
Norethindrone Acetate
Polyestradiol phosphate
Progesterone